Tessenderlo Group (TESB) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
8 Jul, 2026Executive summary
2024 was marked by a 9.6% revenue decline to €2,647.7 million and a 61.5% drop in profit to €44.0 million, with leadership changes including a new CFO and CTO.
Major investments included €35 million in chlorination/ferric chloride plants and the launch of a new weaving machine in China.
Strategic acquisitions, notably Tiger-Sul, expanded the North American footprint and diversified into dry sulfur-based fertilizers.
Significant restructuring and plant closures occurred in the gelatin/Bio-valorization segment, with €40.5 million in restructuring costs.
Share repurchase and cancellation programs were executed, with further buybacks planned.
Financial highlights
Revenue declined by 9.6% to €2,647.7 million; adjusted EBITDA fell 16.7% to €265.6 million; adjusted EBIT dropped 46.8% to €63.8 million.
Net profit for the year was €44.0 million; basic EPS decreased to €0.70.
Operating cash flow rose 52% to €333.2 million; net financial debt position improved to -€5.0 million.
Capital expenditures totaled €180.6 million, split between growth and maintenance.
Board proposes a gross dividend of €0.75 per share for 2024.
Outlook and guidance
2025 adjusted EBITDA is expected between 2023 (€318.7 million) and 2024 (€265.6 million) levels.
High economic and geopolitical uncertainty anticipated to persist in 2025.
Effective tax rate guidance is 25%-26%.
CapEx for 2025 guided at €150 million, with major projects nearing completion.
Latest events from Tessenderlo Group
- Adjusted EBITDA rose 10.7% to €288.1M, but net loss reached €80.2M due to impairments and FX losses.TESB
H2 202530 Mar 2026 - Revenue and profit fell, but net cash and Agro segment improved; outlook remains cautious.TESB
H1 202423 Jan 2026 - Revenue up 7.1%, but net loss of €9.0M due to FX losses and margin pressure.TESB
H1 202523 Nov 2025